Medicine Overview of Safglim VG Tablet
Side Effects of Safglim VG are Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Taste change, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Safglim VG 1mg Tablet is to be taken with food.
Safglim VG 1mg Tablet may cause stomach upset if taken on empty stomach.
Safglim VG 1mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
In Depth Information on Safglim VG Tablet
Safglim VG Tablet related warnings
Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
WEIGH RISKS VS BENEFITS
Safglim VG 1mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Safglim VG 1mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Safglim VG 1mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Safglim VG 1mg Tablet may be needed. Please consult your doctor.
Use of Safglim VG 1mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Safglim VG 1mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Safglim VG 1mg Tablet may be needed. Please consult your doctor.
Safglim VG 1mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Frequently asked questions about Safglim VG Tablet
Safglim vg is a combination of three medicines :Glimepiride+Metformin+Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM) along with diet and exercise to improve blood glucose levels in these patients. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha glucosidase inhibitor which lowers the post-prandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.
Q. What are the possible side effects of Safglim vg?
The use of Safglim vg is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhoea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Q. Are there any specific conditions in which Safglim vg should not to be taken?
The use of Safglim vg should be avoided in patients with known allergy to any of the component or excipients of this medicine. The use of this medicine is also contraindicated in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
Q. Is it safe to take alcohol while I am also taking Safglim vg?
No, it is not safe to take Safglim vg along with alcohol, as it may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.
Q. Can the use of Safglim vg cause hypoglycemia?
Yes, the use of Safglim vg can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, do more than routine exercise or take other antidiabetic medicine along with. So, regular monitoring of blood sugar level is important and be always keep glucose tablets, honey or fruit juice with you.
Q. Does Safglim vg expire?
Yes, Safglim vg does expire. Please check the expiry date written on the pack of this medicine. Do not use Safglim vg after the expiry date.
One of the following vendor pharmacies will deliver Safglim VG 1mg Tablet: BBS, KIS, EEC, WAD, DRA, BDI, HCP, PHC, QLF, APS, PRL, SSA, SNG, DPL, HNP, AVB, SAF, KMC, ESY, EPS, MPC, MKS, SWP, ABP, SLN, RDR, TOM, KLC, DZY, RSA, DYG, VDH, NVL, NNH, EMB, WHL, HSM, TNH, GPP, ATL, PNT, VJS, SYN, OBS, ANP, HIP, GEO, VNS, MDO, OWP, AAR, PRC, RHW, JBT, BAP, MSD, BHP, BNT, MAX, MDH, SDE, FGH, HBV, BIO, PRN, LMS, CHP, SNH, AMH, IMC, STS, AYU, AWS, MLC, NTL, PVP, RDH, RPP, KHD, HSP, IPL, TAT, ZVP, GMA, HPP, NXG, RAC, CPK, HEX, BHA, MAM, AYM, DLP, TSS, JVO, HPC, ARD, KNH, BHS, NTB, JJE, HGI, SSI, PTI, YMI, AXM, BLE, CRN, JHC, ANT, VHP, BBN, VSC, UHP, RKS, SBA, NVY, BSN, DHP, RSS, BLS, GNC, JIV, SBL, BNA, TRP, SGC, SWA, SWT, RHL, NDP, GTK, SHD, HLT, AVL, ASP, KHC, AGT, VOP, AYN, JVN, GTC, DHR, PRT, MAP, EQN, SCH, BTM, XMX, MBP, BRC, KHH, RWP, PMA, OLT, SCP, GHR, SVS, VRS, DVH, GDA, DAO, INC, SJP, EAN, FRM, AFT, AMR, SVH, BLP, ATP, RPI, UVD, RGH, THP, STA, AAY, 4IT, PHN, VSL, CMC, MAK, OHM, DFP, HTS, WPL, UMP, GBL, SPD, PPR, HMP, GPT, RUS, MMS, LHP, BHM, SMN, GLM, NSL, ALC, MKT, NEO, HZF, ENP, 9MM, PLT, DYL, PWN, DPP, SRG, ZPR, BGS, LHA, USF, NNP, BJP, VTR, PTP, GLD, AVS, DGN, SMS, SDM, JSL, WSI, NAS, SHC, ZEL, 1MH, IAD, ADT, TFP, OIP, BDN, LCC, BMJ, CLT, SGH, QTM, HAT, BAL